Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease

[1]  Mahmoud Zarrini,et al.  Mathematical Modeling of an Avalanche Release and Estimation of Flow Parameters by Numerical Method , 2011 .

[2]  N. Dahdah,et al.  First Recanalization of a Coronary Artery Chronic Total Obstruction in an 11-Year-Old Child with Kawasaki Disease Sequelae Using the CROSSER Catheter , 2007, Pediatric Cardiology.

[3]  H. Yanagawa,et al.  Prevalence of coronary artery abnormality in incomplete Kawasaki disease , 2007, Pediatrics international : official journal of the Japan Pediatric Society.

[4]  Paul D. Mitchell,et al.  Coronary Artery Involvement in Children With Kawasaki Disease: Risk Factors From Analysis of Serial Normalized Measurements , 2007, Circulation.

[5]  S. Kitamura,et al.  Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. , 2007, American heart journal.

[6]  S. Takatsuki,et al.  Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[7]  S. Kurotobi,et al.  Application of signal-averaged electrocardiogram to myocardial damage in the late stage of Kawasaki disease. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[8]  R. Holman,et al.  Kawasaki Syndrome and Risk Factors for Coronary Artery Abnormalities: United States, 1994–2003 , 2006, The Pediatric infectious disease journal.

[9]  R. Rodeheffer,et al.  Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.

[10]  Yoshikazu Nakamura,et al.  Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[11]  K. Takahashi,et al.  Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Diastolic Dysfunction in Children with Kawasaki Disease , 2005, Pediatric Cardiology.

[12]  M. Davies,et al.  Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations , 2004, Heart.

[13]  A. Korach,et al.  N‐terminal pro‐B‐type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases , 2004, Acta paediatrica.

[14]  J. Bartunek,et al.  Brain and other natriuretic peptides: molecular aspects , 2004, European journal of heart failure.

[15]  R. Uehara,et al.  Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[16]  M. Drazner,et al.  B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.

[17]  T. Mueller,et al.  Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. , 2003, Clinical chemistry.

[18]  B. McCrindle,et al.  Clinical Relevance of the Risk Factors for Coronary Artery Inflammation in Kawasaki Disease , 2003, Pediatric Cardiology.

[19]  N. Dahdah,et al.  Electrocardiographic Depolarization and Repolarization: Long-Term After Kawasaki Disease , 2002, Pediatric Cardiology.

[20]  J. Furui,et al.  Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease: Quantitative Coronary Artery Angiography and Intravascular Ultrasound Imaging Study , 2002, Circulation.

[21]  T. Kawamura,et al.  Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease , 2002, Cardiology in the Young.

[22]  H. Yanagawa,et al.  Thirty Year Perspective of Cardiac Sequelae of Kawasaki Disease (KD) in Hawaii , 2002, Pediatric Research.

[23]  S. Shulman,et al.  Circulating Cardiac Troponin I Levels in Kawasaki Disease , 2001, Pediatric Cardiology.

[24]  C. Chi,et al.  Clinical spectrum of Kawasaki disease in infants. , 2001, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[25]  H. Kawaguchi,et al.  Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease , 2000, Pediatrics international : official journal of the Japan Pediatric Society.

[26]  S. Colan,et al.  Abnormal myocardial mechanics in Kawasaki disease: Rapid response to γ-globulin , 2000 .

[27]  M. Ghazizadeh,et al.  Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease. , 1999, Microvascular research.

[28]  K. Kim,et al.  Elevation of Cardiac Troponin I in the Acute Stage of Kawasaki Disease , 1999, Pediatric Cardiology.

[29]  K. Kim,et al.  Changes in cardiac troponin I in Kawasaki disease before and after treatment with intravenous gammaglobulin. , 1998, Japanese circulation journal.

[30]  C. Kao,et al.  Labeled WBC Cardiac Imaging and Two‐Dimensional Echocardiography to Evaluate High‐Dose Gamma Globulin Treatment in Kawasaki Disease , 1995, Clinical nuclear medicine.

[31]  K. Nakao,et al.  Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. , 1992, Journal of hypertension.

[32]  T. Nakada,et al.  Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. , 1992, Japanese circulation journal.

[33]  C. Kao,et al.  Tc‐99m HMPAO Labeled WBC Scan for the Detection of Myocarditis in Different Phases of Kawasaki Disease , 1992, Clinical nuclear medicine.

[34]  J. Newburger,et al.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. , 1991, The Journal of pediatrics.

[35]  M. Takahashi.  Myocarditis in Kawasaki syndrome. A minor villain? , 1989, Circulation.

[36]  S. Colan,et al.  Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. , 1989, Circulation.

[37]  H. Nakano,et al.  Clinical characteristics of myocardial infarction following Kawasaki disease: report of 11 cases. , 1986, The Journal of pediatrics.

[38]  S. Kaplan,et al.  Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. , 1985, American heart journal.

[39]  T. Kamiya,et al.  Cardiac biopsy in Kawasaki disease , 1981, Heart and Vessels.

[40]  Y. Hamashima,et al.  Pathology of the heart in Kawasaki disease. , 1978, Pediatrics.

[41]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[42]  M. Rauh,et al.  NT-Pro-B-type Natriuretic Peptide in Infants and Children: Reference Values Based on Combined Data from Four Studies , 2008, Pediatric Cardiology.

[43]  F. Baquero-Artigao,et al.  Coronary Involvement in Infants with Kawasaki Disease Treated with Intravenous γ-Globulin , 2007, Pediatric Cardiology.

[44]  W. Tang.  B-type natriuretic peptide: a critical review. , 2007, Congestive heart failure.

[45]  T. Mir,et al.  N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability , 2006, Clinical chemistry and laboratory medicine.

[46]  T. Kamiya,et al.  Incidence of Stenotic Lesions Predicted by Acute Phase Changes in Coronary Arterial Diameter During Kawasaki Disease , 2004, Pediatric Cardiology.

[47]  H. Kanamaru,et al.  Estimation of “Selective” Intravenous Gamma Globulin Treatment Indicated by Harada Score , 2003 .

[48]  S. Colan,et al.  Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. , 2000, American heart journal.

[49]  K. Nakao,et al.  Molecular biology and biochemistry of the natriuretic peptide system , 1996 .

[50]  J. Newburger,et al.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. , 1991, The Journal of pediatrics.